Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Laruelle

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Psychopharmacology|September 22, 2005
Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycleSusan E Best, Philip M Sarrel, Robert T Malison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2012
Imaging changes in synaptic acetylcholine availability in living human subjectsIrina Esterlis, Jonas O Hannestad, Frederic Bois, et al.
Synapse (New York, N.Y.)|April 6, 2004
In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-racloprideRajesh Narendran, Dah-Ren Hwang, Mark Slifstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PETSharon Ashworth, Eugenii A Rabiner, Roger N Gunn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Prefrontal dopamine D1 receptors and working memory in schizophreniaAnissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, et al.
Psychopharmacology|November 29, 2002
Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652Justine M Kent, Jeremy D Coplan, Ilise Lombardo, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2010
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidoneW Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallyprideLawrence S Kegeles, Mark Slifstein, W Gordon Frankle, et al.
Biological Psychiatry|May 4, 2010
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patientsDaniel R Rosell, Judy L Thompson, Mark Slifstein, et al.
Psychopharmacology|September 6, 2006
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635W Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Psychopharmacology|September 22, 2005
Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycleSusan E Best, Philip M Sarrel, Robert T Malison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 20, 2012
Imaging changes in synaptic acetylcholine availability in living human subjectsIrina Esterlis, Jonas O Hannestad, Frederic Bois, et al.
Synapse (New York, N.Y.)|April 6, 2004
In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-racloprideRajesh Narendran, Dah-Ren Hwang, Mark Slifstein, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2010
Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PETSharon Ashworth, Eugenii A Rabiner, Roger N Gunn, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Prefrontal dopamine D1 receptors and working memory in schizophreniaAnissa Abi-Dargham, Osama Mawlawi, Ilise Lombardo, et al.
Psychopharmacology|November 29, 2002
Occupancy of brain serotonin transporters during treatment with paroxetine in patients with social phobia: a positron emission tomography study with 11C McN 5652Justine M Kent, Jeremy D Coplan, Ilise Lombardo, et al.
Journal of Psychopharmacology (Oxford, England)|November 27, 2010
Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidoneW Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 18, 2008
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallyprideLawrence S Kegeles, Mark Slifstein, W Gordon Frankle, et al.
Biological Psychiatry|May 4, 2010
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patientsDaniel R Rosell, Judy L Thompson, Mark Slifstein, et al.
Psychopharmacology|September 6, 2006
Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635W Gordon Frankle, Ilise Lombardo, Lawrence S Kegeles, et al.
Pageof 11